Nordic Bioscience
Herlev · Founded 1991
About Nordic Bioscience
Nordic Bioscience is a biotech firm that studies extracellular matrix (ECM). It uses Protein Fingerprint technology to identify ECM fragments released from affected tissues and to develop blood-based biomarker assays to quantify disease activity in the pursuit of precision medicine. Nordic Bioscience is based in Herlev, Denmark, and operates a high-quality standard laboratory that conducts clinical trials in accordance with Good Clinical Laboratory Practice (GCLP) and is accredited by the College of American Pathologists (CAP), and has an ISO9001 certificate.
Company Facts
- Founded: 1991
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $100.0M
- Funding stage: Private Equity
- Last round: Private Equity (Mar 2021)
- Website: nordicbioscience.com
- Phone: +45 44 52 52 52
Industries & Categories
Biotechnology, Health Care, Medical, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/nordic-bioscience-19760 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.